BCG Tuberculosis Vaccine Shows Promise in Cutting Insulin Use for Type 1 and LADA Diabetes, Trial Finds
A phase II clinical trial suggests that the century-old BCG tuberculosis vaccine may help regulate blood sugar levels in patients with type 1 and type 1.5 diabetes. Participants receiving the vaccine showed improved blood sugar control and a significant reduction in insulin dependency over a five-year period.
Why it matters
Repurposing an existing, low-cost vaccine for diabetes treatment could significantly improve quality of life and reduce healthcare costs for millions of autoimmune patients.
DUBAI 33°C GOLD/FOREX PRAYER TIMES NEWSLETTERS LOGIN GOLD/FOREX DUBAI 33°C PRAYER TIMES WORLD WORLD GULF MENA EUROPE AFRICA AMERICAS ASIA AUSTRALIA-NEW ZEALAND CORRECTIONS World / Americas Century-old TB vaccine could reduce insulin use in diabetes patients, trial finds Repurposed, low-cost jab slows progression of ‘type 1.5’ diabetes in adults
The article reports on scientific trial findings using objective medical data.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in